有機化學人才網 | 最新人才 | 最新職位 | 技術交易 | 藥物合成 |
   
全站搜索: |
  您當前位置:網站首頁 >> 藥物合成路線圖解
 

藥物詳細合成路線

Name Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax
Chemical Name (8S)-7-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid 1-ethyl ester
CAS 83647-97-6
Related CAS 94841-17-5 (HCl)
Formula C22H30N2O5S2
Structure
Formula Weight 466.6228
Stage 上市-1995
Company Essex (Originator), Novartis (Originator), Schering-Plough (Originator), Pfizer (Licensee)
Activity/Mechanism CARDIOVASCULAR DRUGS, Hypertension, Treatment of, Angiotensin-I Converting Enzyme (ACE) Inhibitors
Syn. Route 4
Route 1
a new synthesis of spirapril has been described:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethanedithiol by means of boron trifluoride ethearate in glacial acetic acid gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is deprotected with hbr in acetic acid to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). this compound is then condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (iv) by means of n-hydroxysuccinimide (nos) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (dmcc) in dmf, or by means of n,n-disuccinimidyl carbonate and pyridine.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (iv)
Reference 1:
    swiss, g.f.; neustadt, b.r.; mcnamara, p.; baum, t.; smith, e.m.; gold, e.h.; sybertz, e.j.; angiotensin converting enzyme inhibitors: spirapril and related. j med chem 1989, 32, 7, 1600-6.

Route 2
a new synthesis of spirapril has been reported:the cyclization of n-benzyloxycarbonyl-4-oxo-(s)-proline (i) with ethandithiol by means of boron trifluoride ethearate in dichloromethane gives 7-(benzyloxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (ii), which is treated with concentrated hcl to yield 1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxylic acid (iii). the protection of (iii) with tert-butoxycarbonyl chloride and with trimethylsilylethanol in the usual manner affords n-(tert-butoxycarbonyl)-1,4-dithia-7-azaspiro[4.4]nonane-8(s)-carboxyli c acid 2-(trimethylsilyl)ethyl ester (iv), which is condensed with n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine (v) by a first treatment with p-toluenesulfonic acid and a condensation step with dicyclohexylcarbodiimide (dcc) and hydroxybenzotriazole (hbt), giving spirapril 2-(trimethylsilyl)ethyl ester (vi). finally, this ester is hydrolyzed with tetrabutylammonium fluoride trihydrate in dmf.
List of intermediates No.
tert-butyl 2-[[(1r)-2-[(2s)-2-([[(1s)-5-[[(benzyloxy)carbonyl]amino]-1-(1,3-thiazol-2-ylcarbonyl)pentyl]amino]carbonyl)pyrrolidinyl]-1-(cyclohexylmethyl)-2-oxoethyl](tert-butoxycarbonyl)amino]acetate (i)
1-methoxy-4-[(4-methoxyphenyl)disulfanyl]benzene; bis(4-methoxyphenyl) disulfide (ii)
4-methoxybenzenesulfinyl chloride (iii)
(1s,2r)-2-phenylcyclohexanol (v)
4-[(4-methoxyphenyl)sulfinyl]benzaldehyde (iv)
6-nitro-2,3-dihydro-4h-chromen-4-one (vi)
Reference 1:
    powell, j.r.; cushman, d.w.; krapcho, j.; turk, c.; deforrest, j.m.; spitzmiller, e.r.; karanewsky, d.s.; duggan, m.; rovnyak, g.; schwartz, j.; et al.; angiotensin-converting enzyme inhibitors. mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. j med chem 1988, 31, 6, 1148.

Route 3
the cyclization of 1-benzyloxycarbonyl-4-oxoproline methyl ester (i) with ethanedithiol (ii) by means of p-toluenesulfonic acid in refluxing acetic acid gives methyl 7-benzyloxycarbonyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iii), which is deprotected with 20% hbr to give methyl 1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate (iv). the condensation of (iv) with n-benzyloxycarbonyl alanine n-hydroxysuccinimide ester (v) affords the corresponding dipeptide methyl ester (vi), which is hydrolyzed with naoh to the free acid (vii), and deprotected with 20% hbr as before to 7-alanyl-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid (viii). finally, this compound is condensed with ethyl 2-oxo-4-phenylbutyrate (ix) by means of sodium cyanoborohydride in methanol.
List of intermediates No.
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
ethyl 3-bromo-4-hydroxy-5-iodobenzoate (i)
ethyl 3-bromo-4-(2-hydroxyethoxy)-5-iodobenzoate (ii)
3-chlorophenylboronic acid (a)
(iii)
(iv)
2,3,3a,4,5,6-hexahydro-1h-phenalen-1-one oxime (v)
(vi)
8-(7,8,9,9a-tetrahydro-1h-phenalen-3-yl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (vii)
(3r)-3-(palmitoyloxy)tetradecanoic acid (viii)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

Route 4
the condensation of (ix) with alanine benzyl ester (x) with sodium cyanoboohydride as before gives n-[1-(ethoxycarbonyl)-3-phenylpropyl]alanine benzyl ester (xi), which is submitted to fractional crystallization with maleic acid yielding n-[1(s)-(ethoxycarbonyl)-3-phenylpropyl]-(s)-alanine benzyl ester (xii), which is debenzylated by hydrogenation with h2 over pd/c in ethanol yielding the free acid (xiii). finally, this compound is condensed with spirane (iv) through the n-hydroxysuccinimide ester, in the usual way.
List of intermediates No.
1-(2-fluoro[1,1-biphenyl]-4-yl)-1-propanone (x)
(1s,2r)-2-phenylcyclohexanol (xiii)
2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)-1h-pyrazol-3-yl]acetonitrile (xii)
2-(4-[[(e)-benzylidene]amino]phenyl)butanenitrile (ix)
methyl 1-methyl-5-nitro-1h-imidazol-2-yl sulfide; 1-methyl-2-(methylsulfanyl)-5-nitro-1h-imidazole (a)
(iv)
(1r)-1-(2-[[(4ar,6r,7r,8r,8as)-6-(benzyloxy)-8-hydroxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-yl]amino]-2-oxoethyl)dodecyl palmitate (xi)
Reference 1:
    smith, e.m.; neustadt, b.r.; gold, e.h. (schering corp.); 7-carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids. jp 1989163197; us 4470972 .
Reference 2:
    prous, j.; castaner, j.; spirapril. drugs fut 1987, 12, 9, 860.

來源:藥化網

作者:藥化小編

摘要:本文合成路線介紹的是藥物中文名螺普利;英文名Spirapril;TI-211-950(hydrochloride);Sch-33844(HCl);Setrilan;Sandopril;Renormax;CAS[83647-97-6]

 
推薦VIP企業
無錫景耀生物科技有限公司
杭州盧普生物科技有限公司
寧波賽倫化工有限公司
蘇州昊賽生物科技有限公司
北京嘉盛揚醫藥科技有限公司
上海澤涵生物醫藥科技有限公司
河北固安三利化工公司
鄭州凱普瑞生物技術有限公司
上海藥谷藥業有限公司
蘭州康寓信生物科技有限公司
湖北朗昕生化藥業有限公司
武漢福鑫化工有限公司
嘉興市英南化工有限公司
蘇州迪飛醫藥科技有限公司
唐山盛源澤興化工有限公司
上海盛中醫藥化工有限公司
連云港天和化學有限公司
南京晨瑞醫藥科技有限公司
南京蘇如化工有限公司
常州瑞盛化工有限公司
熱門文章
由內剖析行業發展需求,向外放眼
河南首批19家化工類產業集聚區
安道麥收購巴拉圭重要農資經銷商
廣西匯豐新工廠竣工投產,年產農
豐山集團擬投資16.30億元建
醫用活性成分——茶樹油在國內農
巴斯夫擬關閉位于美國和德國的兩
瑞士宣布將禁止出口已被禁用的百
美國環境保護署提議批準拜耳的四
如何減少冬季病害傳播?
12月2日,73個批件待領取,
中國農科院在海洋天然產物除草劑
這個藥被稱為萬能藥,專治各種疑
揭秘:農藥成分和含量一模一樣,
河南星火農業擬投建毒死蜱、硝磺
118家農藥企業被列為2020
重磅!農藥廣告審查發布新規定,
全球首款BCL-2新藥中國上市
巴西建立起首個專業的害蟲生物防
注意!應急管理部印發《危險化學
 友情鏈接
有機化學人才網  
首頁 | 廣告服務 | 建站服務 | 關于我們 | 聯系我們 | 版權聲明
江苏快三下载官方网站 山东微信麻将 麻将必胜软件 36选7近100期开奖 乐彩论坛17500 重庆时时官网开奖图 网页炸金花棋牌游戏 内蒙古十一选五分布图 上海晓游游戏 福建31选7规则 微乐吉林麻将下载 四川快乐12任选5遗漏 十一运夺金杀号预测汇总 手机麻将透视软件2019 平特四肖连精准网站 火箭vs爵士g4 斗地主现金版